Automate Your Wheel Strategy on UNCY
With Tiblio's Option Bot, you can configure your own wheel strategy including UNCY - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol UNCY
- Rev/Share 0.0
- Book/Share 0.0096
- PB 60.8295
- Debt/Equity 0.0486
- CurrentRatio 1.6398
- ROIC -2.5732
- MktCap 70797160.0
- FreeCF/Share -0.0266
- PFCF -2.2761
- PE -45.1178
- Debt/Assets 0.0196
- DivYield 0
- ROE -0.7804
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 3
- P/B Score 1
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | UNCY | Guggenheim | -- | Buy | -- | $6 | April 21, 2025 |
News
Unicycive Therapeutics to Present at Upcoming Investor Conferences
Published: May 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ALTOS, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive Officer will present at two upcoming virtual investment conferences.
Read More
Unicycive Therapeutics Announces the Publication of Preclinical Data on Synergies Between Oxylanthanum Carbonate and Tenapanor in American Society of Nephrology Journal Kidney360
Published: February 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ALTOS, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced the publication of preclinical data describing the benefits of combination treatment of oxylanthanum carbonate (OLC) and tenapanor on phosphate management in the American Society of Nephrology (ASN) journal, Kidney360.
Read More
About Unicycive Therapeutics, Inc. (UNCY)
- IPO Date 2021-07-12
- Website https://www.unicycive.com
- Industry Biotechnology
- CEO Dr. Shalabh K. Gupta M.D., MPA
- Employees 22